JPRN-UMIN000010789已完成4 期
Effects of eplerenon in chronik kidney disease with hypertension - Eplerenon in chronik kidney disease
Division of Nephrology, Department of Internal medicine, Jichi Medical University0 个研究点目标入组 30 人开始时间: 2013年5月23日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)diabetes mellitus with microalbuminuria or proteinuria 2)patinets who have allegry for eplerenon 3)hyperkalemia (> 5.5 mEq/ml) 4)chronic kidney disease patients whose eGFR is under 50ml/min/1.73m2 5)severe liver dysfunction 6)patinets who are taking potassiums or potassium-sparing diuretics 7)pregnant women 8)patinets who are taking itraconazole, ritonavir or nelfinavir 9)patinets who will not give informed concent
研究者
相似试验
招募中
不适用
Outcomes in chronic Kidney disease by purified Eicosapentaenoic acids for the prevention of HAZardous events:A Multicenter rAndomized control trial (OKEHAZAMA Trial)Chronic kidney diseaseJPRN-UMIN000013375Fujita Health University School of Medicine300
招募中
2 期
Renal Protective Effect of Esaxerenone in CKD Patients with HypertensioJPRN-jRCT1061230053Masaki Takao20
招募中
不适用
Randomized controlled trials of the renal protective effects of exerenone versus hydrochlorothiazide in hypertensive patients with CKD already on ACEI or ARB therapy.chronic kidney diseaseJPRN-UMIN000042560Yokohama City University Medical Center50
招募中
1 期
Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCRCentral serous chorioretinopathyIRCT20220122053792N1Oroumia University of Medical Sciences34
进行中（未招募）
不适用
Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients with Hypertension (EPOCH)proteinuric patients suffering from chronic kidney disease (II - III) ,diabetes mellitus II and hypertensionEUCTR2012-002175-34-ATMed. Univ. Wien, Universitätsklinik f. Innere Medizin III, Abt. f. Nephrologie und Dialyse24